VYNE
VYNE Therapeutics Inc. Common Stock
$0.65
0.62%
+0.00
Notify me if price changes either direction
Buy VYNE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
21.8M
Enterprise value
-3305342
Trailing PE
0.70820665
Forward PE
-0.39290908
PEG Ratio
-0.011803444166667
Enterprise to EBITDA
0.136
Enterprise to revenue
-7.28
Price to book MRQ
0.8772665
Price to sales TTM
47.672977
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
454.0K
EBITDA
-24345000
Diluted EPS TTM
-0.51
Total Cash (MRQ)
24.9M
Current ratio (MRQ)
20.865
Operating Cash Flow (TTM)
-25744000
VYNE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
